While Martin Shkreli became notorious for sharply increasing drug prices, this duo has quietly plied their trade helping to kick-start drug company sales.
DebugScreen: mobile
{
"author": {
"name": "Andrew Martin",
"webUrl": "/author/profile/andrew-martin/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 1,
"social": [],
"articles": [
{
"uri": "/2018/04/10/the-duo-quietly-helping-pharmacy-companies-raise-p/",
"title": "The duo quietly helping pharmacy companies raise prices",
"byline": "Jared S Hopkins and Andrew Martin",
"kicker": "Investigation",
"prettyDate": "April 10, 2018",
"timeToRead": "12 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/RisingHealthCosts.jpg",
"width": "600",
"height": "385"
},
"authors": [
{
"webUrl": "/author/profile/jared-s-hopkins/",
"name": "Jared S Hopkins"
},
{
"webUrl": "/author/profile/andrew-martin/",
"name": "Andrew Martin"
}
],
"kickerNode": [
{
"uri": "/investigation/",
"sectionName": "Investigation"
}
],
"summary": "While Martin Shkreli became notorious for sharply increasing drug prices, this duo has quietly plied their trade helping to kick-start drug company sales.",
"body": null
}
]
}
}